Effectiveness of Inactivated and mRNA COVID-19 Vaccines Against SARS-CoV-2 Infection, Severe Disease and Mortality in the Geriatric Population

Older age (>60 years) has been identified as the main risk factor for COVID-19. In this study, we aimed to evaluate the efficacy of Pfizer–BioNTech and CoronaVac vaccines against COVID-19 infection, serious illness, and mortality in the geriatric population. We found that 2 doses of CoronaVac vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Genç Bahçe, Yasemin, Acer, Ömer, Özüdoğru, Osman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169106/
https://www.ncbi.nlm.nih.gov/pubmed/37160453
http://dx.doi.org/10.1007/s00284-023-03322-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169106/
https://www.ncbi.nlm.nih.gov/pubmed/37160453
http://dx.doi.org/10.1007/s00284-023-03322-z

Ejemplares similares